- Trials with a EudraCT protocol (297)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (43)
297 result(s) found for: hepatitis A vaccine.
Displaying page 1 of 15.
EudraCT Number: 2006-001638-42 | Sponsor Protocol Number: 057-00 | Start Date*: 2006-09-22 | |||||||||||
Sponsor Name:MSD (Norge) AS | |||||||||||||
Full Title: Study to Assess the Safety, Tolerability, and Immunogenicity of 2 Antigen Doses of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process Administered to Healthy Infants at 2, 4, and ... | |||||||||||||
Medical condition: Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003649-18 | Sponsor Protocol Number: V232-059-00 | Start Date*: 2007-01-12 | |||||||||||
Sponsor Name:Merck & Co. Inc. | |||||||||||||
Full Title: A Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process | |||||||||||||
Medical condition: Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005023-18 | Sponsor Protocol Number: V232-054-00 | Start Date*: 2005-06-09 | |||||||||||
Sponsor Name:Merck Sharp & Dohme (Sweden) AB | |||||||||||||
Full Title: Study in Healthy Young Adults to Assess the Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured by a Process Upgrade | |||||||||||||
Medical condition: Acute hepatitis B without delta-agent and without hepatic coma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002589-38 | Sponsor Protocol Number: HBV-2013 | Start Date*: 2013-07-11 | |||||||||||||||||||||
Sponsor Name:Universität Innsbruck, Institut für Biomedizinische Alternsforschung | |||||||||||||||||||||||
Full Title: Primary and booster vaccination in old age: Hepatitis A and Hepatitis B | |||||||||||||||||||||||
Medical condition: This study will analyze cellular and humoral immune reponses after primary or booster vaccination against HAV and HBV. Healthy adults will be vaccinated with a combination vaccine, which is license... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001639-23 | Sponsor Protocol Number: V232-058 | Start Date*: 2006-09-05 | |||||||||||
Sponsor Name:Merck SHARP & DOHME DE ESPAÑA | |||||||||||||
Full Title: A Study to Assess the Anamnestic Immune Response 4 to 6 Years After a Primary Vaccination Series With HBVAXPRO™ Estudio para evaluar la respuesta inmune anamnésica 4 a 6 años después de una pauta d... | |||||||||||||
Medical condition: Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003981-15 | Sponsor Protocol Number: V232-056 | Start Date*: 2016-09-30 | |||||||||||
Sponsor Name:Merck & Co., Inc. | |||||||||||||
Full Title: A Study in Healthy Neonates of Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured Using a Modified Process | |||||||||||||
Medical condition: Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005939-10 | Sponsor Protocol Number: V232-055 | Start Date*: 2006-05-15 | |||||||||||
Sponsor Name:Merck & Co. Inc. | |||||||||||||
Full Title: A study in healthy, young adults and healthy infants of the safety, tolerability, and immunogenicity of an investigational manufacturing process for the recombinant hepatitis B vaccine | |||||||||||||
Medical condition: Hepatitis B ICD10 classification code : Hepatitis Viral- Type B (ICD10- B16) MedDRA classification code : Infections and Infestations – Viral Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022538-10 | Sponsor Protocol Number: 112688 | Start Date*: 2011-04-05 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: An open, phase IV, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B (Engerix-B™ Kinder) vaccine challenge in children... | |||||||||||||
Medical condition: Antibody persistence and hepatitis B vaccine challenge in children aged 7–8 years, previously primed and boosted with 4 doses of GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) as part of... | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003484-22 | Sponsor Protocol Number: PNC+AHEP | Start Date*: 2012-09-11 |
Sponsor Name:Helsinki University Central Hospital | ||
Full Title: Immune response to pneumococcal conjugate vaccine in adults receiving hepatitis A vaccine concomitantly | ||
Medical condition: 18 years old or older volunteers with general good health | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003650-20 | Sponsor Protocol Number: V232-060-02 | Start Date*: 2007-02-19 | |||||||||||
Sponsor Name:Merck & Co Inc., | |||||||||||||
Full Title: A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured with a Modified Process | |||||||||||||
Medical condition: Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004785-98 | Sponsor Protocol Number: OVG2008/5 | Start Date*: 2008-12-22 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: An observational study of children immunised in infancy against hepatitis B virus, evaluating the persistence of immunity and the immune response to a scheduled booster dose of hepatitis B vaccine | |||||||||||||
Medical condition: The intended application of Engerix B is active immunisation against Hepatitis B virus infection caused by all known subtypes in non immune subjects. | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000261-38 | Sponsor Protocol Number: 108988 | Start Date*: 2008-01-21 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase IV, open, multicentric study to evaluate the immune response to a hepatitis B challenge dose in healthy subjects, 72 to 78 months after they received a primary vaccination course of GSK Bio... | ||
Medical condition: Hepatitis B vaccine challenge dose given to subjects, 17 to 21 years of age, to evaluate immune memory to Hepatitis B antigen, approximately 6 years after priming with Hepatitis B vaccine. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001918-15 | Sponsor Protocol Number: 116763 | Start Date*: 2014-04-28 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A phase IV, open-label, single-centre study to assess the long-term persistence of hepatitis A antibodies in healthy adults, primed 21 to 25 years earlier with GSK Biologicals’ hepatitis A vaccine ... | |||||||||||||
Medical condition: Healthy volunteers (Vaccination against hepatitis A in healthy adults) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022372-31 | Sponsor Protocol Number: DV2-HBV-19 | Start Date*: 2011-11-10 | |||||||||||
Sponsor Name:Dynavax Technologies Corporation | |||||||||||||
Full Title: An Observational Study Evaluating the Long-Term Safety and Immunogenicity of HEPLISAV™ Compared with Engerix-B® in Adults With Chronic Kidney Disease Who Have Previously Received a Hepatitis B Vacc... | |||||||||||||
Medical condition: Prevention of Hepatitis B virus (HBV) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001508-37 | Sponsor Protocol Number: 113681 | Start Date*: 2015-05-22 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: Phase III randomized, open, controlled study to evaluate the immune response to the hepatitis B antigen of the RTS,S/AS01E candidate vaccine, when administered as primary vaccination integrated int... | ||
Medical condition: Healthy volunteers (Primary immunization against Plasmodium falciparum malaria, immunization against hepatitis B) | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2016-002720-91 | Sponsor Protocol Number: HBnr02 | Start Date*: 2017-09-21 |
Sponsor Name:CyTuVax BV | ||
Full Title: Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders. | ||
Medical condition: In a minority of the population (5-10%) standard vaccines against Hepatitis-B do not induce protective immunity, even after prolonged and repeated vaccination courses. Non- responsiveness to hepati... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002574-39 | Sponsor Protocol Number: 207811 | Start Date*: 2018-11-08 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: Ancillary study evaluating ChAd155-hIi-HBV shedding in a subset of chronic hepatitis B patients enrolled in the first-time-in-human, Phase I/II, randomised, multi-centric, single-blind study TH HBV... | |||||||||||||
Medical condition: Chronic hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016721-33 | Sponsor Protocol Number: rHB01C | Start Date*: 2010-09-09 | |||||||||||
Sponsor Name:Sanofi Pasteur MSD S.N.C | |||||||||||||
Full Title: A Study to Estimate the Immune Response Following a Challenge Dose in Adults (≥ 50 years old) Vaccinated With a Primary Series of an Hepatitis B Vaccine | |||||||||||||
Medical condition: Healthy subjects, active immunisation against Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005999-41 | Sponsor Protocol Number: 109063 | Start Date*: 2007-01-23 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: A phase III, randomized, open, controlled, multicenter primary vaccination study to demonstrate the non inferiority of the immunogenicity of GSK Biologicals’ meningococcal serogroup ACWY conjugate ... | ||
Medical condition: Primary immunization of healthy subjects aged 11 through 17 years against meningococcal serogroups A, C, W 135 and Y and/or hepatitis A and hepatitis B diseases | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003756-32 | Sponsor Protocol Number: HEP/UNI-001 | Start Date*: 2016-06-10 | ||||||||||||||||
Sponsor Name:Central Manchester University Hospitals NHS Foundation Trust | ||||||||||||||||||
Full Title: A pilot study evaluating the influence of chronobiology on Hepatitis B responses in health-care students attending the University of Salford | ||||||||||||||||||
Medical condition: The immune response to Hepatitis B vaccine is being investigated. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
